Flagship Pioneering
Seed to Growth venture capital firm
Flagship Pioneering is a Seed to Growth venture capital firm that invests in Biotechnology, Genetic Medicine and mRNA Therapeutics. DryPowder has no SEC Form D on file for Flagship Pioneering as of June 3, 2026.
Updated · Sources: fund website
- Stages
- Seed–Growth
Overview
Flagship Pioneering at a glance
- Stage
- Seed, Early-Stage, Growth
- Sectors
- Biotechnology, Genetic Medicine, mRNA Therapeutics, Agricultural Biotech, Life Sciences
- Cold inbound
- Warm intro preferred
- Website
- flagshippioneering.com
Investment thesis
For over 25 years, Flagship Pioneering has endeavored to make the impossible possible, pushing the boundaries of knowledge to pioneer a better future for people and the planet through breakthroughs defined by the people behind them.
Stated on flagshippioneering.comWEBSITE
What sets Flagship Pioneering apart
- Deep founder-partnership model with CEO-Partners embedded in portfolio companies
- Creation-stage investing (founding companies with scientific platforms rather than backing existing founders)
- 25+ year track record with multiple billion-dollar exits (Moderna)
- Strategic pharma partnerships (Pfizer, GSK, Genentech, Novo Nordisk) providing downstream validation
Recent investments
DryPowder has tracked these recent investments from Flagship Pioneering: Serif Biomedicines and Etiome.
What the portfolio shows
Portfolio 15
Backed: Moderna, Tessera Therapeutics, Generate:Biomedicines + 12 more
Partners
Partners at Flagship Pioneering
Team data is not yet available for Flagship Pioneering. Visit the website
Similar funds
Funds like Flagship Pioneering
IndieBioClimate, Healthcare · $100K–$500K
LifeSci Venture PartnersBiotechnology, Medical Devices · $500K–$15M
Ben Franklin Technology PartnersTechnology, Life Sciences · $25K–$500K
Investor lists that include Flagship Pioneering
FAQ
Questions about Flagship Pioneering
What does Flagship Pioneering invest in?
Flagship Pioneering is a Seed, Early-Stage, Growth stage Biotechnology, Genetic Medicine, MRNA Therapeutics, Agricultural Biotech, Life Sciences investor, primarily investing in US. Their thesis: For over 25 years, Flagship Pioneering has endeavored to make the impossible possible, pushing the boundaries of knowledge to pioneer a better future for people and the planet through breakthroughs defined by the people behind them.
What makes Flagship Pioneering different from other funds?
Flagship Pioneering stands out on 4 points: Deep founder-partnership model with CEO-Partners embedded in portfolio companies; Creation-stage investing (founding companies with scientific platforms rather than backing existing founders); 25+ year track record with multiple billion-dollar exits (Moderna); Strategic pharma partnerships (Pfizer, GSK, Genentech, Novo Nordisk) providing downstream validation.
What has Flagship Pioneering invested in recently?
Recent investments DryPowder has tracked from Flagship Pioneering include Serif Biomedicines, Etiome.
What other funds are similar to Flagship Pioneering?
Funds with an overlapping stage and sector focus include IndieBio, LifeSci Venture Partners, Ben Franklin Technology Partners.
How do I reach Flagship Pioneering?
Flagship Pioneering does not generally take cold inbound; a warm introduction from a founder or investor the firm knows is the usual path.
Sources
Updated